Trial Profile
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Jan 2020
Price :
$35
*
At a glance
- Drugs Fimasartan (Primary)
- Indications Essential hypertension
- Focus Pharmacokinetics
- Sponsors Boryung Pharmaceutical
- 05 May 2011 New trial record